ArticlePloS one2019

A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity.

Lauren Zebertavage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.